CATALOGO DEI PRODOTTI DELLA RICERCA

BONADONNA, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.157
EU - Europa 8.013
AS - Asia 6.263
SA - Sud America 913
AF - Africa 223
Continente sconosciuto - Info sul continente non disponibili 223
OC - Oceania 23
Totale 25.815
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.935
RU - Federazione Russa 2.874
SG - Singapore 2.710
GB - Regno Unito 2.000
CN - Cina 1.464
IT - Italia 778
BR - Brasile 740
HK - Hong Kong 561
VN - Vietnam 515
DE - Germania 446
SE - Svezia 413
FR - Francia 410
FI - Finlandia 358
IE - Irlanda 297
KR - Corea 283
BD - Bangladesh 249
UA - Ucraina 124
CA - Canada 104
NL - Olanda 84
IN - India 79
AR - Argentina 69
JP - Giappone 60
NG - Nigeria 58
MX - Messico 57
TR - Turchia 57
ID - Indonesia 53
PK - Pakistan 48
ZA - Sudafrica 43
AT - Austria 37
BJ - Benin 36
IQ - Iraq 33
BE - Belgio 30
PL - Polonia 26
ES - Italia 25
UZ - Uzbekistan 23
CO - Colombia 21
EC - Ecuador 21
AU - Australia 19
VE - Venezuela 17
EG - Egitto 15
SA - Arabia Saudita 15
CL - Cile 14
PH - Filippine 14
GR - Grecia 13
LT - Lituania 12
DZ - Algeria 11
MA - Marocco 11
AE - Emirati Arabi Uniti 10
BG - Bulgaria 10
CR - Costa Rica 10
JO - Giordania 10
RO - Romania 10
TN - Tunisia 10
HR - Croazia 9
MY - Malesia 9
PY - Paraguay 9
BO - Bolivia 8
ET - Etiopia 8
GH - Ghana 8
KE - Kenya 8
UY - Uruguay 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
HN - Honduras 7
NP - Nepal 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
AL - Albania 6
DO - Repubblica Dominicana 6
IL - Israele 6
IS - Islanda 6
KG - Kirghizistan 6
CH - Svizzera 5
IR - Iran 5
JM - Giamaica 5
NI - Nicaragua 5
OM - Oman 5
PE - Perù 5
TH - Thailandia 5
KZ - Kazakistan 4
LV - Lettonia 4
TW - Taiwan 4
BY - Bielorussia 3
BZ - Belize 3
DK - Danimarca 3
EE - Estonia 3
HU - Ungheria 3
KH - Cambogia 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PA - Panama 3
SN - Senegal 3
SV - El Salvador 3
TG - Togo 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
CY - Cipro 2
Totale 25.557
Salva come PNG Salva come JPEG
Città #
Southend 1.682
Singapore 1.343
Ashburn 1.306
Jacksonville 992
San Jose 951
Dallas 942
Moscow 917
Woodbridge 743
Chandler 740
Hong Kong 554
Houston 385
Verona 357
Council Bluffs 334
Ann Arbor 319
Dublin 298
The Dalles 288
New York 241
Beijing 226
Ho Chi Minh City 180
Los Angeles 173
Wilmington 143
Lawrence 142
Princeton 142
Nanjing 108
Buffalo 107
Hanoi 103
Santa Clara 86
Sindelfingen 82
Shenyang 81
Boardman 80
Redondo Beach 78
Helsinki 72
Milan 71
Munich 66
Jinan 65
São Paulo 65
London 61
Abuja 52
Tokyo 50
Hebei 47
Columbus 46
Amsterdam 45
Seoul 43
Changsha 42
Tianjin 41
Cotonou 36
Phoenix 35
Nanchang 34
Nuremberg 34
Orem 32
San Francisco 32
Chicago 31
Frankfurt am Main 31
Falkenstein 30
Zhengzhou 30
Brussels 29
Turku 29
Haikou 28
Montreal 27
Hangzhou 26
Rio de Janeiro 25
Toronto 25
Brasília 24
Redmond 24
Washington 24
Ningbo 23
Rome 23
Guangzhou 22
Warsaw 22
Haiphong 21
Jakarta 21
Atlanta 20
Bologna 20
Johannesburg 20
Tashkent 20
Belo Horizonte 19
Da Nang 18
Stockholm 18
Taiyuan 18
Vienna 18
Brooklyn 17
Mianwali 17
Norwalk 17
Shanghai 17
Taizhou 17
Jiaxing 16
Baghdad 15
Curitiba 15
Dearborn 15
Dhaka 15
Mexico City 15
Lancaster 14
Romola 14
Seattle 14
Chennai 13
Denver 13
Falls Church 13
Mumbai 13
Philadelphia 13
Redwood City 13
Totale 16.074
Salva come PNG Salva come JPEG
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 785
Common Variants Associated to Type 2 Diabetes in the Italian Population 498
Adipocytes IGFBP-2 expression in prepubertal obese children. 342
VARIABLES INFLUENCING THE OPTIMAL SAMPLING DURATION OF INTERMITTENTLY-SCANNED CONTINUOUS GLUCOSE MONITORING TO ASSESS 90 DAYS OF GLYCEMIA RISK INDEX. FINDINGS FROM A MULTICENTRIC REAL-WORLD STUDY. 249
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 248
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 232
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 222
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 219
11-6: CONTINUOUS GLUCOSE MONITORING AND ASSESSMENT OF LONG-TERM ISLET FUNCTION IN AUTOLOGOUS ISLET TRANSPLANTATION AFTER TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA: PRELIMINARY DATA FROM THE VERONA COHORT 218
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. 207
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 206
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 201
High-fat meal, systemic inflammation and glucose homeostasis in obese children and adolescents 199
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 197
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 197
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 196
Assessment of β-cell function during the oral glucose tolerance test by a minimal model of insulin secretion 194
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 194
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 191
A compartmental model to quantitate in vivo glucose transport in the human forearm 188
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 187
Pathogenesis of NIDDM. A balanced overview. 187
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 184
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 181
Fat cell size, insulin sensitivity, and inflammation in obese children. 180
Confronto degli effetti metabolici dell'esercizio aerobico e dell'esercizio di forza nel diabete tipo 2 180
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion 175
Beta-cell function across the spectrum of glucose tolerance in obese youth. 175
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 174
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 173
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects 172
Insulin sensitivity and beta-cell function: Relationships to glycemic control in newly diagnosed Type 2 diabetic patients 172
Metabolic and hormonal consequences of two different meals after a moderate intensity exercise bout in obese prepubertal children 172
A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study 171
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) 170
Continuous Glucose Monitoring and Long-Term Assessment of Islet Function in Autologous Islet Transplantation after Total Pancreatectomy for Neoplasm: Preliminary Insights from a Prospective Study 169
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease 162
Angiotensin-Converting Enzyme genotype and Endothelium-Dependent Vasodilation of Conduit Arteries and Forearm Microcirculation in Humans 161
Alterations of glucose metabolism in type 2 diabetes mellitus. An overview. 161
“IGT-like” status in normoglucose tolerant obese children and adolescents: the additive role of glucose profile morphology and 2-hours glucose concentration during the oral glucose tolerance test 161
Operation of Randle's cycle in patients with NIDDM 160
Angiotensin converting enzyme inhibitors improve endothelial function in type I (insulin-dependent) diabetic patients with normal arterial pressure and microalbuminuria 160
HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. 159
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 158
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 156
“Genetic Load” of diabetes risk alleles affects beta-cell function in patients with newly diagnosed type 2 diabetes 155
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 155
Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. 154
Ghrelin, insulin sensitivity and postprandial glucose disposal in overweight and obese children. 154
Defects in the dynamic control of beta cell function and in glucose effectiveness underly the initial decline in intravenous glucose tolerance of obese European children 152
Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus 151
Effects of physiological hyperinsulinemia on the intracellular metabolic partition of plasma glucose 151
Vitamin D affects insulin sensitivity and β-cell function in obese non-diabetic youths 151
Metabolic control analysis (MCA) of intravenous glucose tolerance in healthy humans. 149
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. 149
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 019 It's beta cell replacement time: 402 - Continuous glucose monitoring and assessment of islet function in autologous islet transplantation after total pancreatectomy for pancreatic neoplasia: preliminary data from the Verona cohort 147
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 147
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 145
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity 145
Obesity and insulin resistance in man. A dose response study 143
Estimation of blood flow heterogeneity in human skeletal muscle using intravascular tracer data: importance for modeling transcapillary exchange 141
Effect of insulin on system A amino acid transport in human skeletal muscle 141
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 141
The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus 140
Pathogenetic Mechanisms and Cardiovascular Risk: Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance. 139
Pleiotropic Effects of GIP on Islet Function Involve Osteopontin. 138
In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia 138
Evaluating endothelial function of the common carotid artery: An in vivo human model. 137
Glucose metabolism in obesity and type 2 diabetes 135
Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. 133
Estimation of blood flow heterogeneity distribution in human skeletal muscle from positron emission tomography data 132
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 131
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study 131
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14 127
Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance 127
U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population: The Bruneck study 127
Metabolic and thermogenic effects of lactate infusion in humans 126
Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus 126
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients 126
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 125
Time dependence of the interaction between lipid and glucose in humans 125
Free fatty acid and glucose metabolism in human aging: evidence for operation of the Randle cycle 125
Sintesi di glicogeno, glicolisi ed ossidazione glucidica nel paziente obeso con diabete tipo II. Contributo alla insulinoresistenza. 125
Bicarbonate kinetics in humans: identification and validation of athree-compartment model 124
Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. 123
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. 123
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 123
Platelet and clotting activities after cold stress in diabetic patients 122
Phasic insulin release and metabolic regulation in type 2 diabetes 122
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 120
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 119
Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans 119
Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. 118
Insulin resistance and vasodilation in essential hypertension. Studies with adenosine 117
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 117
Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man 117
Effect of prolonged overnight fasting on energy metabolism in non-insulin-dependent diabetic and non-diabetic subjects 116
Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus 116
Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women 116
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. 116
Totale 16.755
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.415
article - articoli 74.095
book - libri 0
conference - conferenze 11.120
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 200
Totale 170.830
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022702 0 0 19 97 25 36 9 58 36 36 94 292
2022/20232.155 174 184 227 384 220 474 29 151 201 13 63 35
2023/20241.476 38 96 95 149 143 200 67 356 6 89 154 83
2024/20253.833 181 205 130 681 148 96 217 197 661 223 349 745
2025/202611.060 803 629 969 1.723 2.545 726 1.184 614 659 555 337 316
2026/2027589 244 338 7 0 0 0 0 0 0 0 0 0
Totale 25.815